9,447
Total Claims
$1.3M
Drug Cost
1,546
Beneficiaries
$810
Cost/Patient
Peer Comparison vs. 218,535 Nurse Practitioner providers
-31%
Cost per patient vs peers
$810 vs $1,174 avg
+58%
Brand preference vs peers
14.0% vs 8.9% avg
Brand vs Generic
86% generic
Brand: 1,327 claims · $1.1M
Generic: 8,120 claims · $161K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 696 | $671K |
| Sacubitril/Valsartan | 130 | $145K |
| Rivaroxaban | 112 | $116K |
| Ticagrelor | 62 | $36K |
| Dronedarone Hcl | 23 | $36K |
| Icosapent Ethyl | 61 | $25K |
| Evolocumab | 27 | $23K |
| Metoprolol Succinate | 828 | $14K |
| Ranolazine | 103 | $13K |
| Atorvastatin Calcium | 730 | $8,824 |
| Bumetanide | 270 | $8,535 |
| Dofetilide | 42 | $7,197 |
| Diltiazem Hcl | 136 | $6,221 |
| Pitavastatin Calcium | 13 | $5,777 |
| Isosorbide Mononitrate | 457 | $5,649 |
Prescribing Profile
65
Unique Drugs
$932K
Patient Profile
75
Avg Age
47%
Female
1.75
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About